StreamLink 15 CC
Screening Separation System (line development)
Biopharmaceutical drug discovery and development, like mononuclear antibody (mAbs), need molecule development and Cell Line Development (CLD). It is especially relevant for treatment areas like cell and cancer therapies. Clarification and purification are elementary filtration work steps for mAbs cell culture sample preparation. The StreamLink® CC 15 can do both. Current filtration steps take up too much time and labor. The efficiency of the Streamlink® CC 15 makes it beneficial in small biotech companies as well as in large pharmaceutical groups. Even universities, academies and research centers will profit of the device performance.
Client / Manufacturer
Design
Sartorius Stedim Biotech GmbH
Göttingen, DECorpus-C Design Agentur GmbH
Fürth, DECorpus-C Design TeamDate of Launch
2022
Development Time
up to 36 Month
Target Regions
North America, South America, Africa, Asia, Australia / Oceania, Europe
Target Groups
Trade / Industry